Evidence map›Paper›PMID 41907633›Full record

ArticleFrontiers in oncology2026

Exploring the recurrence and metastasis of breast invasive ductal carcinoma based on machine learning and survival analysis.

Aqiao Xu, Xiaobo Weng, Jing Zheng, Qian Cui, Gaoyan He, Yongran Cheng, Haitao Jiang, Mingzhu Wei, Shengjian Zhang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aqiao Xu *Department of Radiology, The Central Hospital Affiliatedo Shaoxing University (Shaoxing Central Hospital), Shaoxing, China.
Xiaobo Weng *Department of Radiology, The Central Hospital Affiliatedo Shaoxing University (Shaoxing Central Hospital), Shaoxing, China.
Jing ZhengDepartment of Radiology, The Central Hospital Affiliatedo Shaoxing University (Shaoxing Central Hospital), Shaoxing, China.
Qian CuiDepartment of Radiology, The Central Hospital Affiliatedo Shaoxing University (Shaoxing Central Hospital), Shaoxing, China.
Gaoyan HeDepartment of Radiology, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.
Yongran ChengSchool of Public Health, Hangzhou Medical College, Hangzhou, China.
Haitao JiangDepartment of Radiology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Mingzhu WeiDepartment of Radiology, Shaoxing People's Hospital (Zhejiang University Shaoxing Hospital), Shaoxing, China.
Shengjian ZhangDepartment of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Invasive ductal carcinoma (IDC), the predominant histopathological subtype comprising about 80% of breast malignancies, continues to pose a significant clinical challenge due to frequent recurrence. Existing relapse prediction models remain limited in accuracy and generalizability. This study aimed to construct and validate machine learning-based models for predicting 5-year (short- to medium term) recurrence and metastasis risk in IDC, based on recurrence-free survival (RFS) analysis. Methods: A total of 640 IDC cases diagnosed between January 2017 and December 2019 were enrolled, data were partitioned into three sets: the training set (n = 303) from Fudan University Shanghai Cancer Center; the validation set (n = 217) from Shaoxing Central Hospital; and the test set (n = 120) from Zhejiang Cancer Hospital. Independent prognostic factors were identified through univariate and multivariate Cox regression analyses. Three predictive strategies were implemented: evaluating recurrence risk, distinguishing local from distant recurrence, and identifying metastatic sites. Light Gradient Boosting Machine (LGBM), XGBoost (XGB), Random Forest (RF), k-Nearest Neighbor (KNN), Neural Network (NN), and Support Vector Machine (SVM) were trained and validated. Results: The median follow-up duration was 5.7 years. Multivariate Cox regression analyses identified multiple factors significantly associated with RFS, including the rad-score, Ki-67 index, lymph node metastasis, tumor histological grade, and breast cancer family history in first- or second-degree relatives (all Conclusion: This study underscores the utility of machine learning models in forecasting recurrence and metastatic behavior in IDC. The clinical-radiomic nomograms proved valuable for individualized surgical and therapeutic decision-making in IDC patients.

Indexed as

invasive ductal carcinomamachine learningmetastasisradiomicsrecurrence-free survival

Identifiers

PMID41907633
PMCPMC13021447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.